An Observational Study of Patients With Metabolic Syndrome and Related Conditions

Target PharmaSolutions

Status

Not yet enrolling

Conditions

Metabolic Syndrome

Study type

Observational

Funder types

Industry

Identifiers

NCT05842811

TARGET-METABOLIC

Details and patient eligibility

About

TARGET-METABOLIC is an observational research study to conduct a comprehensive review of outcomes for patients with metabolic syndrome and related conditions.

Enrollment

2,000,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Disease Cohort

Inclusion Criteria:

Adult patients at the time of enrollment with a diagnosis of metabolic syndrome or related conditions by ICD-10 code or with clinically calculated BMI ≥ 30 in the EHR/health system interface

Exclusion Criteria:

Death
Manual removal (sponsor or site request)
No EHR interface encounter > 3 years

Engaged Cohort

Inclusion Criteria:

Adult patients diagnosed and managed for these conditions invited to participate
Ability to provide written informed consent

Exclusion Criteria:

Patient expressed desire to withdraw consent to complete PROs
Failure to complete PROs within 24 weeks of initial invitation
Greater than 24 months lapse of survey completion after baseline surveys completed
Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort